This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device. (CGM QOL)

Cedars-Sinai Medical Center

Status: Not yet enrolling

Conditions: Diabetes Mellitus

Study type: Observational

Funder types: Other

Identifiers

NCT06965803

STUDY00003936

Details and patient eligibility

About

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Enrollment: 37 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• aged 18 or older
• diagnosed with Type 1 or Type 2 Diabetes who are on insulin
• able to speak and understand English language
• scheduled to receive a standard inpatient diabetes education consultation
• must not have used CGM in the six months prior to admission
• owns a smartphone
• demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

Exclusion criteria

• those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
• non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.